Slowik M R, De Luca L G, Min W, Pober J S
Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, Conn. 06536-0812, USA.
Circ Res. 1996 Oct;79(4):736-47. doi: 10.1161/01.res.79.4.736.
Tumor necrosis factor (TNF) activates transcription of endothelial leukocyte adhesion molecule-1 (CD62E) in endothelial cells (ECs) through the binding to the gene promoter of the p50/p65 heterodimeric form of nuclear factor-kappa B (NF-kappa B) and of the N-terminal phosphorylated form of the ATF2/c-Jun transcription factor, which is phosphorylated by Jun N-terminal kinase (JNK). However, the intracellular signaling pathways that activate endothelial NF-kappa B and JNK in TNF-induced responses are unknown. In this study we have examined the role of a recently described TNF signaling pathway involving sphingomyelin activation to generate ceramide, a potential intracellular mediator. We find that concentrations of TNF that strongly activate NF-kappa B and JNK within 15 minutes do not produce either a measurable decline in sphingomyelin or a measurable generation of ceramide in cultured human umbilical vein ECs at any time examined. Stimulation of ECs with purified sphingomyelinase (SMase) enzyme causes a rapid 60% to 80% decrease in cellular sphingomyelin content and a large increase in ceramide. However, SMase treatment only minimally activates NF-kappa B, achieving levels that are insufficient to initiate gene transcription. Extracellular SMase does not have access to intracellular sphingomyelin, but treatment of ECs with membrane-permeant ceramide analogues still completely fails to activate NF-kappa B and only activates JNK at late times. Neither SMase nor ceramide analogues induce gene transcription or surface expression of endothelial leukocyte adhesion molecules that are readily induced by TNF. Strikingly, low concentrations of membrane-permeant ceramide cause programmed cell death in ECs, a finding not observed at any concentrations of TNF tested. We conclude that ceramide is not an important second messenger for TNF signaling of gene transcription in ECs but may be a second messenger for cell death in response to as-yet-unidentified signals.
肿瘤坏死因子(TNF)通过与核因子κB(NF-κB)的p50/p65异二聚体形式的基因启动子以及由Jun N端激酶(JNK)磷酸化的ATF2/c-Jun转录因子的N端磷酸化形式结合,激活内皮细胞(ECs)中内皮白细胞黏附分子-1(CD62E)的转录。然而,在TNF诱导的反应中激活内皮NF-κB和JNK的细胞内信号通路尚不清楚。在本研究中,我们研究了最近描述的涉及鞘磷脂激活以生成神经酰胺的TNF信号通路的作用,神经酰胺是一种潜在的细胞内介质。我们发现,在培养的人脐静脉ECs中,在任何检测时间,能在15分钟内强烈激活NF-κB和JNK的TNF浓度都不会导致鞘磷脂出现可测量的下降或神经酰胺的可测量生成。用纯化的鞘磷脂酶(SMase)刺激ECs会导致细胞鞘磷脂含量迅速下降60%至80%,神经酰胺大幅增加。然而,SMase处理仅能轻微激活NF-κB,达到的水平不足以启动基因转录。细胞外SMase无法接触到细胞内鞘磷脂,但用膜通透性神经酰胺类似物处理ECs仍然完全无法激活NF-κB,并且仅在后期激活JNK。SMase和神经酰胺类似物均未诱导TNF容易诱导的内皮白细胞黏附分子的基因转录或表面表达。令人惊讶的是,低浓度的膜通透性神经酰胺会导致ECs发生程序性细胞死亡,这一发现在所测试的任何TNF浓度下均未观察到。我们得出结论,神经酰胺不是ECs中TNF基因转录信号传导的重要第二信使,但可能是对尚未确定信号作出反应的细胞死亡的第二信使。